From: Can probiotics play a role in Helicobacter pylori (H. Pylori) eradication?
Item | Standard therapy | Probiotic therapy | Odd ratio (95% CI) | P value |
Patients randomized | 59 | 100 | Â | Â |
Patients lost to follow-up | 4 | 5 | ||
Patients followed up | 55 | 95 | ||
Patients with H. pylori eradication | 42 | 78 | ||
Patients resist H. pylori eradication | 17 | 22 | ||
Intention to treat analysis | 71.19% (42/59) | 78.00% (78/100) | 0.69 (0.33–1.45) | 0.335 |
Per-protocol analysis | 69.09% (38/55) | 76.84% (73/95) | 0.79 (0.51–1.22) | 0.297 |
 | Standard therapy | Probiotics before standard therapy | Odd ratio (95% CI) | P value |
Patients randomized | 59 | 42 | Â | Â |
Patients lost to follow-up | 4 | 2 | ||
Patients followed up | 55 | 40 | ||
Patients with H. pylori eradication | 42 | 31 | ||
Patients resist H. pylori eradication | 17 | 11 | ||
Intention to treat analysis | 71.19% (42/59) | 73.81% (31/42) | 0.87 (0.36–2.13) | 0.772 |
Per-protocol analysis | 69.09% (38/55) | 72.50% (29/40) | 0.85 (0.34–2.08) | 0.719 |
 | Standard therapy | Probiotic after standard therapy | Odd ratio (95% CI) | P value |
Patients randomized | 59 | 58 | Â | Â |
Patients lost to follow-up | 4 | 3 | ||
Patients followed up | 55 | 55 | ||
Patients with H. pylori eradication | 42 | 47 | ||
Patients resist H. pylori eradication | 17 | 11 | ||
Intention to treat analysis | 71.19% (42/59) | 81.04% (47/58) | 0.58 (0.24–1.37) | 0.021* |
Per-protocol analysis | 69.09% (38/55) | 80.00% (44/55) | 0.53 (0.27–1.30) | 0.018* |
 | Probiotics before standard therapy | Probiotic after standard therapy | Odd ratio (95% CI) | P value |
Patients randomized | 42 | 58 | Â | Â |
Patients lost to follow-up | 2 | 3 | ||
Patients followed up | 40 | 55 | ||
Patients with H. pylori eradication | 31 | 47 | ||
Patients resist H. pylori eradication | 11 | 11 | ||
Intention to treat analysis | 73.81% (31/42) | 81.04% (47/58) | 0.66 (0.26 – 1.70) | 0.389 |
Per-protocol analysis | 72.50% (29/40) | 80.00% (44/55) | 1.52 (0.58 – 3.95) | 0.392 |